menu
    • menu

    Company profile for Moksha8 Pharmaceuticals

    NEW Drugs in Dev: 3
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    moksha8 is a specialty pharmaceutical company focused on the commercialization of innovative and established therapeutics in the two major Latin America markets, Brazil and Mexico. Our understanding of the regulatory complexities, our stringent quality assurance, our adherence to international standards and our integrated service offering make us the perfect partner for pharmaceutical companies looking to establish, maintai...
    moksha8 is a specialty pharmaceutical company focused on the commercialization of innovative and established therapeutics in the two major Latin America markets, Brazil and Mexico. Our understanding of the regulatory complexities, our stringent quality assurance, our adherence to international standards and our integrated service offering make us the perfect partner for pharmaceutical companies looking to establish, maintain or expand their business presence in the major two Latin America Pharmaceuticals markets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Moksha8 PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1055 Westlakes Dr, Berwyn, PA 19312
    Telephone
    Telephone
    +16107274018
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://moksha8.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/moksha8/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Food Ingredients China

    Not Confirmed

    envelop Contact Supplier

    Food Ingredients China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    M8, signs an exclusive agreement with SERB to bring Voraxaze to Latin America
    M8, signs an exclusive agreement with SERB to bring Voraxaze to Latin America

    20 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/m8-pharmaceuticals-an-acino-company-signs-an-exclusive-agreement-with-serb-pharmaceuticals-to-bring-voraxaze-glucarpidase-to-latin-america-302093643.html

    PR NEWSWIRE
    20 Mar 2024
    Share Share
    M8 Pharma Announces License of Exclusive rights MED3000 from Futura Medical
    M8 Pharma Announces License of Exclusive rights MED3000 from Futura Medical

    31 Aug 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/m8-pharmaceuticals-announces-license-of-exclusive-rights-med3000-from-futura-medical-for-latin-america-301365521.html

    PRNEWSWIRE
    31 Aug 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search